-
Erasca Inc. (ERAS $16.63)
- $16.63 Cap: $4.65B
- View ERAS Profile
- View Questions on ERAS
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Erasca Inc. (ERAS $16.63)
- $16.63 Cap: $4.65B
- View ERAS Profile
- View Questions on ERAS
-
ADMA Biologics Inc (ADMA $9.10)
- $9.10 P/E (TTM): 15.25X Cap: $2.14B
- View ADMA Profile
- View Questions on ADMA
Q: Hi team,
Your views on these two companies ? A buy for a growth portfolio or something better in the health sector ?
Gratefully,
Jacques IDS
Your views on these two companies ? A buy for a growth portfolio or something better in the health sector ?
Gratefully,
Jacques IDS
Insiders
Share Information
SEC Filings
News and Media